This story has it all...motel chicanery...13D...collusion...SEC/DOJ...insider trading...CEO jail time...FDA hardliners...intrigue/meddling/indifference...only thing missing is Impeachment.

_______________________________________________________________

Keytruda forecast is $23.8Bn FOR 2025....while Humira declined to $1.68Bn with biosimlars chewing up the market after Patent expiration...quite a drop from $20.BN in 2022.

Combined better than $25.Bn X ????...it's good to be the King of inflammation.

To all of my American friends...Happy 4TH!!!